The Spanish Agency for Medicines and Health Products (AEMPS) has published an information note reminding stakeholders that the new fragrance allergen labelling requirements established by Commission Regulation (EU) 2023/1545 are now applicable. The measure expands the...
The AEMPS has reactivated the NotificaCS portal, an online tool intended for the notification of undesirable effects associated with the use of cosmetic products. After a period of maintenance, the NotificaCS tool includes improvements in security and usability, with...
On October 10, the AEMPS (Spanish Agency for Medicines and Health Products) published the 2024 Cosmetic Products Market Surveillance Report. During 2024, market surveillance of cosmetic products in Spain was strengthened, with the aim of ensuring the safety and...
On May 6, 2025, the Spanish Agency for Medicines and Health Products (AEMPS) issued a new warning regarding the use of hyaluronidase in aesthetic settings, highlighting the risks associated with its improper application as an injectable product when marketed as a...
The Spanish Agency for Medicines and Medical Devices (AEMPS), in collaboration with the Ministry of the Presidency, Justice, and Relations with Parliament, has launched the automatic processing of the Hague Apostille for Free Sale Certificates (CLV) and Export...
The Spanish Agency for Medicines and Health Products (AEMPS), has learned, through a study carried out by the Organization of Consumers and Users (OCU), of alleged non-compliance in the labeling of seven sunscreens. The AEMPS, as the competent authority in controlling...
According to the 2023 Cosmetovigilance Report, the AEMPS received and investigated 120 notifications, of which 74% were not serious. Of them, 30% corresponded to skin care products, 28% to deodorants, 10% to solar products and 7% to depilatories. In addition, another...
In order to facilitate the management of cosmetics exporting companies, the AEMPS reports a new function in the CERTCOS_CLV application, now available on the AEMPS electronic headquarters. This new function allows up to four applications to be grouped in the same...
The Spanish Agency of Medicines and Medical Devices (AEMPS) published, on January 26th, the informative note COS, 01/2024 regarding the cessation of commercialization and use of several batches of Orravan Distilled Water. These measures were ordered by the Government...
The AEMPS has published detailed information on the guarantees applicable to cosmetic products. These guarantees reported by AEMPS are applicable in the European Union. And, it also refers to some additional guarantees included in the legislation in Spain. The...
The new CERTCOS_CLV application, launched by the AEMPS, aims to facilitate the procedures related to the management of free sale certificates for the export of cosmetic products. The application is developed with the purpose of achieving a greater guarantee of data...
The Spanish Agency for Medicines and Health Products (AEMPS) carries out an Information Campaign on Cosmetic Products 2022. The objective of the campaign is to spread the claims that are inappropriate in cosmetic hydroalcoholic gels and other cosmetic products for...